(Q34235999)

31 July 2017

title

Mycophenolate mofetil in pediatric heart transplant recipients: a single-center experience (English)

1 reference

31 July 2017

3

B W McCrindle

1 reference

31 July 2017

A I Dipchand

1

1 reference

31 July 2017

L Benson

series ordinal

2

1 reference

31 July 2017

J Coles

series ordinal

4

1 reference

31 July 2017

L West

series ordinal

5

1 reference

31 July 2017

publication date

1 April 2001

1 reference

Pediatric Transplantation

31 July 2017

published in

1 reference

31 July 2017

volume

5

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

112-118

1 reference

A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

Pediatric renal transplantation without steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

Anti-T-cell-antibody prophylaxis in children: success with a novel combination strategy of mycophenolate mofetil and antithymocyte serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

Clinical pharmacokinetics of mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

7 January 2021

Mycophenolate mofetil in cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

7 January 2021

The use of tacrolimus and mycophenolate mofetil after cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

7 January 2021

Steroid withdrawal in mycophenolate mofetil-treated renal allograft recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

7 January 2021

Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

7 January 2021

Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

7 January 2021

Mycophenolate mofetil to rescue children with acute renal transplant rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

7 January 2021

Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

7 January 2021

New immunosuppressive agents in pediatric renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005002112.X

7 January 2021

10.1034/J.1399-3046.2001.005002112.X

Identifiers

DOI

1 reference

31 July 2017

1 reference